Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EFAVIRENZ vs EFGARTIGIMOD ALFA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EFAVIRENZ vs EFGARTIGIMOD ALFA: Safety Overview

Metric EFAVIRENZ EFGARTIGIMOD ALFA
Total FAERS Reports 7,893 249
Deaths Reported 962 26
Death Rate 12.2% 10.4%
Hospitalizations 1,528 115
Average Patient Age 40.7 yrs 54.0 yrs
% Female Patients 37.7% 82.5%
FDA Approval Date Apr 27, 2018 N/A
Manufacturer Camber Pharmaceuticals, Inc. argenx US
Route ORAL INTRAVENOUS
Marketing Status Discontinued Prescription